(Q40460874)

20 September 2017

1 reference

title

Which diet for which renal failure: making sense of the options. (English)

1 reference

20 September 2017

Beto JA

1

1 reference

20 September 2017

publication date

1 August 1995

1 reference

Journal of the American Dietetic Association

20 September 2017

published in

1 reference

20 September 2017

volume

95

1 reference

20 September 2017

issue

8

1 reference

20 September 2017

page(s)

898-903

1 reference

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2895%2900248-0

Diabetic nephropathy: a comprehensive approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2895%2900248-0

Controlled low protein diets in chronic renal insufficiency: meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2895%2900248-0

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2895%2900248-0

Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2895%2900248-0

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2895%2900248-0

The familial risk of end-stage renal disease in African Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2895%2900248-0

Nutrition principles for the management of diabetes and related complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2895%2900248-0

US minority groups and end-stage renal disease: a disproportionate share

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2895%2900248-0

Assessing adequacy of hemodialysis: urea modeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2895%2900248-0

Recommendations for reducing the high morbidity and mortality of United States maintenance dialysis patients. The National Kidney Foundation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2895%2900248-0

Anthropometric norms for the dialysis population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2895%2900248-0

Glucose absorption during continuous ambulatory peritoneal dialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2895%2900248-0

A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2895%2900248-0

Effect of nutrition on morbidity and mortality in maintenance dialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2895%2900248-0

10.1016/S0002-8223(95)00248-0

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference